DUOPA, the dopamine pump, was FDA approved in January 2015 as an orphan drug (drugs or products intended for treatment of rare conditions affecting fewer than 200,000 people in the United States).  Though there are probably closer to a million people with Parkinson disease (PD) in the U.S., only a minority would be considered for … Continue reading Thoughts on the dopamine pump, an interview with Conner Moore, M.D. (retired)